Skip to main navigation menu Skip to main content Skip to site footer

Medical staff adherence to thromboprophylaxis for preventing thromboembolic disease in pregnancy and gynecological surgery

Adherencia del personal médico a la tromboprofilaxis para la prevención de enfermedad tromboembólica en la gestante y en cirugía ginecológica



Open | Download


Section
Original Articles

How to Cite
Cortés Cortés, A. J., Ortiz Martínez, R. A. ., Guzmán, E. R. ., Erazo, A. L. ., Cuatí, C. D. ., Muñoz, D. B. ., & Daza, L. V. . (2025). Medical staff adherence to thromboprophylaxis for preventing thromboembolic disease in pregnancy and gynecological surgery. Journal of Medicine and Surgery Repertoire. https://doi.org/10.31260/RepertMedCir.01217372.1677

Dimensions
PlumX
Citations
license

   


Alvaro Jhonny Cortés Cortés,

Residente de III año de la especialización en Ginecología y Obstetricia, Facultad Ciencias de la Salud, Universidad del Cauca


Roberth Alirio Ortiz Martínez,

Docente Universidad del Cauca. Popayán, Colombia.


Laura Valentina Daza,

Estudiante VIII semestre de medicina, Universidad del Cauca Popayán.



##plugins.themes.bootstrap3.displayStats.noStats##

Introduction: venous thromboembolism is one of the most serious and potentially fatal complications associated with pregnancy, childbirth, and gynecological surgery. Objective: to evaluate medical staff adherence to thromboprophylaxis guidelines in pregnancy and gynecological surgery settings, at Hospital Universitario San José in Popayán, during 2021. Methodology: a descriptive cross-sectional study in 2021, including pregnant, postpartum period, and gynecological surgery patients, selected by inclusion and exclusion criteria.  Material and methods: the FECOLSOG and Caprini scales were applied to classify thrombotic events risk, in-hospital adherence, and out-patient prescription in terms of time and dose. Descriptive epidemiology was used for assessing adherence, with a 95% confidence interval. Results and discussion: 807 obstetric patients and 114 gynecological surgery patients were included. Moderate risk was determined in 42.6 % of pregnancy and postpartum period cases, and 64% of gynecological surgery cases were classified as high-risk. In-hospital adherence to thromboprophylaxis in pregnancy and postpartum period was 92% (95% CI: 90-94%) in terms of time and 82% (95% CI: 90-94%) in terms of dose, with 66.7% classified as low-risk in terms of dose.  Out-patient prescription for very high-risk patients was 57.1% and 42,9% in terms of dosage and time, respectively. Outpatient adherence to thromboprophylaxis in gynecological surgery patients in terms of dose and duration was 53% (95% CI: 43% - 62%), while in terms of dose it was 32.9% for patients at high risk for thrombosis. Conclusion: the adherence to inpatient thromboprophylaxis was high in terms of both duration and dosage, but outpatient prescription was low, especially for high and very high-risk patients.


Article visits 5 | PDF visits 1


Downloads

Download data is not yet available.
  1. Cantrell LE, Garcia C, Maitland HS, et al. The prevention and management of thrombosis in obstetrics and gynecology. Thrombosis and thromboprophylaxis in gynecology surgery. Clin Obstet Gynecol. 2018;61(2):269-277. doi: http://dx.doi.org/10.1097/GRF.0000000000000355
  2. Souza JP, Day LT, Rezende-Gomes AC, Zhang J, Mori R, Baguiya A, et al. A global analysis of the determinants of maternal health and transitions in maternal mortality. Lancet Glob Health. 2024;12(2):e306–16. http://dx.doi.org/10.1016/s2214-109x(23)00468-0
  3. Boletín Epidemiológico Semanal. Comportamiento de la morbilidad materna extrema en Colombia, a periodo epidemiológico VII de 2023 [Internet]. Bogotá: Instituto Nacional de Salud (Colombia); 2023 [citado 2023 Mayo 28]. Disponible en: https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2023_Boleti%CC%81n_epidemiologico_semana_30.pdf
  4. Bruno AM, Sandoval GJ, Hughes BL, Grobman WA, Saade GR, Manuck TA, et al. Postpartum pharmacologic thromboprophylaxis and complications in a US cohort. Am J Obstet Gynecol. 2024;231(1):128.e1-128.e11. http://dx.doi.org/10.1016/j.ajog.2023.11.013
  5. Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, et al. American Society of Hematology 2019. Guidelines for management of venous thromboembolism: Prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019;3(23):3898-944. https://doi.org/10.1182/bloodadvances.2019000975
  6. Catella J, Rivoire E, Abejiou I, Quiquandon S, Desmurs-Clavel H, Dargaud Y. Age is a risk factor for poor knowledge about venous thromboembolism treatment. Clin Appl Thromb Hemost. 2024;30: 10760296241276527. http://dx.doi.org/10.1177/10760296241276527
  7. Kayikci U, Fadiloglu E, Cigdem Bayrak A, Alptug Kir E, Esat Temiz B, Deren O. Guideline-based venous thromboprophylaxis in postpartum women: An in-depth evaluation of ACOG and RCOG recommendations and real-life implementation. Eur J Obstet Gynecol Reprod Biol. 2024;299:272–7. http://dx.doi.org/10.1016/j.ejogrb.2024.06.027
  8. Guía de práctica clínica para la prevención de eventos tromboembólicos venosos durante la gestación, el parto o el puerperio. Rev Colomb Obstet Ginecol. 2017;68(4):285-304. http://dx.doi.org/10.18597/rcog.3084
  9. Grupo de Desarrollo de Guías y Documentos de Consenso (GDDC). Consenso de tromboprofilaxis en cirugía ginecológica. Rev Colomb Obstet Ginecol. 2021;72(1):53-68. https://doi.org/10.18597/rcog.3666
  10. Mattar G, Al Sahafi N, Al Hazmi L, Al Hazmi N, Abozeid HE, Sultan I. Evaluation of risk stratification and adherence to venous thromboembolism prophylaxis among hospitalized obstetric women: Retrospective case file review at East Jeddah Hospital during 2018-2019. Ann Thorac Med. 2022;17(2):94-101. https://doi.org/10.4103/atm.atm_79_21
  11. Mérola V, Pizzarossa AC, López M, Peverelli F, Bruno G, González M, et al. Venous thromboembolism risk and adherence to pharmacological thromboprophylaxis in hospitalized patients in Uruguay: first nationwide study. Clin Appl Thromb Hemost. 2024;30:10760296241256368. https://doi.org/10.1177/10760296241256368
  12. Federspiel JJ, Wein LE, Addae-Konadu KL, Darwin KC, Talamo LE, Myers ER, et al. Venous thromboembolism incidence among patients recommended for pharmacologic thromboembolism prophylaxis after cesarean delivery in selected guidelines. J Thromb Haemost. 2021;19(3):830–8. https://doi.org/10.1111/jth.15218
  13. Grille S, Maggiari L, Morales I, Ojeda J, Pérez B, Pérez I, Ribero V, Guillermo C. Adherencia a las recomendaciones de tromboprofilaxis post-cesárea: estudio de corte transversal. Revista Méd Chile. 2021;149(6):881-887. https://doi.org/10.4067/s0034-98872021000600881
  14. Crowley MP, Noone C, Higgins JR, O'Shea SO. A multicentre study of thromboprophylaxis in pregnancy. Ir Med J. 2017;110(5):567.
  15. Zaher GF. Underutilization of pharmacological thromboprophylaxis in obstetrics and gynaecology patients in the absence of a risk assessment tool. J Taibah Univ Med Sci. 2017;13(1):10-15. https://doi.org/10.1016/j.jtumed.2017.08.001
  16. Choy KR, Emmett S, Wong A. Venous thromboembolism prophylaxis in pregnancy: Are we adequately identifying and managing risks? Aust N Z J Obstet Gynaecol. 2022;62(6):915–20. http://dx.doi.org/10.1111/ajo.13579
  17. Silva-Herrera JL, Duque-Giraldo MA, Torres-Chaparro C, Sanín-Blair JE, Niño-Peña ML, Higuita-Rendón AM. Profilaxis tromboembólica en pacientes posparto. Estudio de corte transversal en tres instituciones en Colombia. Rev Colomb Obstet Ginecol. 2016;67(1):20-25. https://doi.org/10.18597/rcog.364
  18. Yu HT, Dylan ML, Lin J, Dubois RW. Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm. 2007;64(1):69-76. https://doi.org/10.2146/ajhp06011
Sistema OJS 3.4.0.5 - Metabiblioteca |